MAOB and Parkinson disease: The most frequently prescribed medication for parkinsonism was levodopa (61 (98.4%) patients), followed by zonisamide (13 (21.0%)), dopamine agonists (12 (19.4%)), monoamine oxidase B inhibitors (eight (12.9%)), catechol‐O‐methyltransferase inhibitors (five (8.1%)), amantadine (three (4.8%)), istradefylline (three (4.8%)), anticholinergic agents (one (1.6%)), and droxidopa (one (1.6%)).